|
Year
|
Title
|
Authors
|
Publication
|
|
2018
|
Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: Analysis of BMT CTN-0201 and 0901 samples
|
Rashidi A, Shanley R, Yohe Sophia L, Thyagarajan B, Curtsinger, J, Anasetti C, Waller E K, Scott BL, Blazar BR, Weisdorf, DJ
|
Br J Haematol 182(6):887-894
|
|
2018
|
Patient-reported outcomes and health status associated with chronic graft-versus-host disease.
|
Lee SJ, Onstad L, Chow EJ, Shaw BE, Jim HSL, Syrjala KL, Baker KS, Flowers ME
|
Haematologica 103(9):1535-1541
|
|
2018
|
Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3Ars7588571 and chronic GVHD
|
Rashidi A, Shanley R, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ
|
Bone Marrow Transplant
|
|
2018
|
SCID genotype and 6-month post-transplant CD4 count predict survival and immune recovery: a PIDTC retrospective study.
|
Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop S, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen A, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai S-Y, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD
|
Blood
|
|
2018
|
Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: Conditioning regimen intensity.
|
Eapen M, Brazauskas R, Hemmer M, Perez WS, Steinert P, Horowitz MM, Deeg HJ
|
Blood Advances 2(16):2095-2103
|
|
2018
|
Comparative analysis of calcineurin-inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of graft-versus-host disease after reduced intensity conditioning allogeneic transplantation.
|
Chhabra S, Liu Y, Hemmer MT, Costa L, Pidala JA, Couriel DR, Alousi A, Majhail NS, Stuart RK, Kim D, Ringden O, Urbano-Ispizua A, Saad A, Savani BN, Cooper B, Marks DI, Socie G, Schouten HC, Schoemans H, Abdel-Azim H, Yared J, Cahn J-Y, Wagner J, Antin JH, Verdonck LF, Lehmann L, Aljurf MD, MacMillan ML, Litzow MR, Solh MM, Qayed M, Hematti P, Kamble RT, Vij R, Hayashi RJ, Gale RP, Martino R, Seo S, Hashmi SK, Nishihori T, Teshima T, Gergis U, Inamoto Y, Spellman SR, Arora M, Hamilton BK
|
Biol Blood Marrow Transplant
|
|
2018
|
KIR donor selection: feasibility in identifying better donors.
|
Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson MD, Vierra-Green C, Spellman SR, Spahn A, Vogel J, Kobusingye H, Fehninger T, Woolfrey A, Devine S, Ross M, Waller EK, Sobecks R, Parham P, Guethlein LA, Marsh SGE, Miller J
|
Biol Blood Marrow Transplant
|
|
2018
|
Pro-inflammatory cytokine and adipokine levels in adult unrelated marrow donors are not associated with hematopoietic cell transplantation outcomes.
|
Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Yingst A, Couriel D, Alousi A, Pidala J, Knight JM, Verneris MR
|
Biol Blood Marrow Transplant
|
|
2018
|
Bone marrow versus peripheral blood from unrelated donors for children and adolescents with acute leukemia.
|
Keesler DA, Martin AS, Bonfim C, Seber A, Zhang M-J, Eapen M
|
Biol Blood Marrow Transplant
|
|
2018
|
Staging systems for newly diagnosed myeloma patients undergoing autologous hematopoietic cell transplant: the revised international staging system shows the most differentiation between groups.
|
Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A
|
Biol Blood Marrow Transplant
|
|
2018
|
Patient HLA germline variation and transplant survivorship.
|
Petersdorf EW, Stevenson P, Malkki M, Strong RK, Spellman SR, Haagenson MD, Horowitz MM, Gooley T, Wang T
|
J Clin Oncol 36(24):2524-2531
|
|
2018
|
Amphiregulin modifies the Minnesota acute graft-versus-host disease risk score: Results from BMT CTN 0302/0802
|
Holtan SG, DeFor TE, Panoskaltsis-Mortari A, Khera N, Levine JE, Flowers MED, Lee SJ, Inamoto Y, Chen GL, Mayer S, Arora M, Palmer J, Cutler CS, Arai S, Lazaryan A, Newell LF, Jagasia MH, Pusic I, Wood WA, Renteria AS, Yanik G, Hogan WJ, Hexnar E, Ayuk F, Holler E, Bunworasate U, Efebera YA, Ferrara J, Pidala J, Howard A, Wu J, Bolaños-Meade J, Ho V, Alousi A, Blazar BR, Weisdorf DJ, MacMillan ML
|
Blood Advances 2(15):1882-1888
|
|
2018
|
Rates and risk factors for post-traumatic stress disorder symptomatology among adult hematopoietic cell transplant recipients and their informal caregivers.
|
Liang J, Lee SJ, Storer BE, Shaw BE, Chow EJ, Flowers ME, Krakow EF, Bar M, Syrjala KL, Salit RB, Kurukulasuriya CE, Jim HSL
|
Biol Blood Marrow Transplant
|
|
2018
|
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
|
Baldomero H, Aljurf M, Zaidi SZA, Hashmi SK, Ghavamzadeh A, Elhaddad A, Hamladji R-M, Ahmed P, Torjemane L, Abboud M, Tbakhi A, Khabori MA, El Quessar A, Bazuaye N, Bekadja MA, Adil S, Fahmy O, Ramzi M, Ibrahim A, Alseraihy A, Ben Abdejalil N, Sarhan M, Huneini MA, Mahmal L, ElSolh H, Hussain F, Nassar A, Al-Hashmi H, Hamidieh AA, Pasquini M, Kodera Y, Kröger N, Mohty M, Jaimovich G, Rolon JM, Paulson K, Greinix H, Weisdorf D, Horowitz M, Nunez J, Gratwohl A, Passweg J, Koh M, Szer J, Niederwieser D, Novitzky N
|
Bone Marrow Transplant
|
|
2018
|
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated.
|
Nikiforow S, Wang T, Hemmer M, Spellman S, Akpek G, Antin JH, Choi SW, Inamoto Y, Khoury HJ, MacMillan M, Marks DI, Meehan K, Nakasone H, Nishihori T, Olsson R, Paczesny S, Przepiorka D, Reddy V, Reshef R, Schoemans H, Waller N, Weisdorf D, Wirk B, Horowitz M, Alousi A, Couriel D, Pidala J, Arora M, Cutler C
|
Haematologica
|
|
2018
|
Association between recipient TNF rs361525 and acute GVHD: Results from analysis of BMT CTN-0201 samples.
|
Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Miller JS, Blazar BR, Weisdorf DJ
|
Bone Marrow Transplant 53(8):1069-1071
|
|
2018
|
Treosulfan, fludarabine and low-dose total body irradiation for children and young adults with acute myeloid leukemia or myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation: A prospective phase II trial of the Pediatric Blood and Marrow Transplant Consortium.
|
Nemecek ER, Hilger RA, Adams A, Shaw BE, Kiefer D, Le-Rademacher J, Levine JE, Yanik G, Leung W, Talano JA, Haut P, Delgado D, Kapoor N, Petrovic A, Adams R, Hanna R, Rangarajan H, Dalal J, Chewning J, Verneris MR, Epstein S, Burroughs L, Perez-Albuerne ED, Pulsipher MA, Delaney C
|
Biol Blood Marrow Transplant 24(8):1651-1656
|
|
2018
|
Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: A secondary data analysis from the BMT CTN 0902 trial.
|
Jim HSL, Sutton S, Majhail NS, Wood WA, Jacobsen PB, Wingard JR, Wu J, Knight JM, Syrjala KL, Lee SJ
|
Bone Marrow Transplant 53(8):1038-1043
|
|
2018
|
Is a matched sibling the ideal donor for hematopoietic cell transplant?
|
Eapen M
|
Haematologica 103(8):1251-1252
|
|
2018
|
Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation.
|
D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE
|
Bone Marrow Transplant 53(8):1079-1082
|
|
2018
|
Reply to The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular lymphoma. (Related to P-4811)
|
Sureda A, Montoto S, Dreger P, Hamadani M, Pasquini MC
|
Cancer 124(16):3455-3456
|
|
2018
|
Machine learning approach to predicting stem-cell donor availability.
|
Sivasankaran A, Williams E, Switzer GE, Cherkassky V, Maiers M
|
Biol Blood Marrow Transplant
|
|
2018
|
Antibiotic practice patterns in hematopoietic cell transplantation: A survey of Blood and Marrow Transplant Clinical Trials Network centers
|
Rashidi A, Holtan, S, Bhatt, A, Wangjam, Tamna, Weisdorf, J
|
Am J Hematol
|
|
2018
|
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.
|
Arrieta-Bolaños E, Crivello P, Shaw BE, Ahn KW, Wang H-L, Verneris MR, Hsu KC, Pidala J, Lee SJ, Fleischhauer K, Spellman SR
|
Blood Advances 2(14):1773-1783
|
|
2018
|
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.
|
Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn J-Y, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK
|
Leuk Res
|
|
2018
|
Reduced intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies BMT CTN 1204
|
Allen C, Marsh R, Dawson P, Bollard C, Shenoy S, Roehrs, P, Hanna R, Burroughs L, Kean L, Talano J, Schultz K, Yun-Pai S, Baker K, Andolina J, Stenger E, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher M
|
Blood
|
|
2018
|
Testing for center effects on survival and competing risks outcomes using pseudo-value regression.
|
Wang Y, Logan BR
|
Lifetime Data Anal
|
|
2018
|
Translation of clinical research into practice: an impact assessment of the results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on unrelated graft source utilization.
|
Khera N, Mau L-W, Denzen E, Meyer C, Houg K, Lee SJ, Horowitz MM, Burns LJ
|
Biol Blood Marrow Transplant
|
|
2018
|
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
|
Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani BN, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR
|
Bone Marrow Transplant 53(7):932-937
|
|
2018
|
Cohort-controlled comparison of umbilical cord blood transplantation using carlecortemcel-L, a single progenitor-enriched cord blood, to double cord blood unit transplantation.
|
Stiff PJ, Montesinos P, Peled T, Landau E, Rosenheimer Goudsmid NR, Mandel J, Hasson N, Olesinski E, Glukhman E, Snyder DA, Galamidi Cohen EG, Srur Kidron OS, Bracha D, Harati D, Ben-Abu K, Freind E, Freedman LS, Cohen YC, Olmer L, Barishev R, Rocha V, Gluckman E, Horowitz MM, Eapen M, Nagler A, Sanz G
|
Biol Blood Marrow Transplant 24(7):1463-1470
|
|
2018
|
Microbiome-host interactions in hematopoietic stem-cell transplant recipients.
|
Andermann T, Peled J, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink M, Alousi A, Balderman S, Chiusolo P, Clark W, Holler E, Howard A, Kean L, Koh A, McCarthy P, McCarty J, Mohty M, Nakamura R, Rezvani K, Segal B, Shaw B, Shpall E, Sung A, Weber D, Whangbo J, Wingard J, Wood W, Perales M-A, Jenq R, Bhatt A
|
Biol Blood Marrow Transplant 24(7):1322-1340
|
|
2018
|
Hospital-level variability in broad-spectrum antibiotic use for children with acute leukemia undergoing hematopoietic cell transplantation.
|
Elgarten CW, Arnold SD, Li Y, Huang Y-V, Riches ML, Gerber JS, Aplenc R, Saber W, Fisher BT
|
Infect Control Hosp Epidemiol 39(7):797-805
|
|
2018
|
A Phase II/III randomized, multicenter trial of Prednisone/Sirolimus vs. Prednisone/Sirolimus/ Calcineurin Inhibitor for treatment of chronic graft-versus-host decease: BMT CTN 0801
|
Carpenter P, Logan BR, Lee, S, Weisdorf D J, Johnston L, Costa L, Kitko C L, Bolanos-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu Jiaxi, O'Brien, Kelly, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler C, Horowitz MM, Arora M
|
Haematologica
|
|
2018
|
B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.
|
Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai S-Y
|
Blood 131(26):2967-2977
|
|
2018
|
Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation.
|
Sullivan KM, Majhail NS, Bredeson C, Carpenter PA, Chatterjee S, Crofford LJ, Georges GE, Nash RA, Pasquini MC, Sarantopoulos S, Storek J, Savani B, St. Clair EW
|
Biol Blood Marrow Transplant
|
|
2018
|
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.
|
Sarhan M, Brandt L, Felices M, Guldevall K, Lenvik T, Hinderlie P, Curtsinger J, Warlick E, Spellman SR, Blazar BR, Weisdorf D, Cooley S, Vallera DA, Önfelt B
|
Blood Advances
|
|
2018
|
Outcomes of measurable residual disease in pediatric acute myeloid leukemia pre- and post-hematopoietic stem cell transplant: validation of difference from normal flow cytometry with chimerism studies and Wilms tumor 1 gene expression.
|
Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JA, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA
|
Biol Blood Marrow Transplant
|
|
2018
|
Female sex is associated with poor health-related quality of life in children at 12 months post-hematopoietic cell transplantation.
|
Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE
|
J Pediatr Hematol Oncol
|
|
2018
|
Risk score for development of veno-occlusive disease after allogeneic hematopoietic cell transplant.
|
Strouse C, Zhang Y, Zhang M-J, DiGilio A, Pasquini MC, Horowitz MM, Lee S, Ho V, Ramananthan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber W
|
Biol Blood Marrow Transplant
|
|
2018
|
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
|
Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja MA, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M
|
Cancer 124(12):2541-2551
|
|
2018
|
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.
|
Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JE
|
Blood Advances 2(11):1198-1206
|
|
2018
|
Related donor transplants: Has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
|
Robinson TM, Fuchs EJ, Zhang M-J, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis J-H, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A
|
Blood Advances 2(11):1180-1186
|
|
2018
|
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
|
Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, Shaw BE, Flowers ME, Ruutu T, Greinix H, Holler E, Basak G, Duarte RF, Pavletic SZ
|
Bone Marrow Transplant
|
|
2018
|
Chromosomal aberrations and survival after unrelated donor hematopoietic stem cell transplant in patients with Fanconi anemia.
|
Wang Y, Zhou W, Alter BP, Wang T, Spellman SR, Haagenson M, Yeager M, Lee SJ, Chanock SJ, Savage SA, Gadalla SM
|
Biol Blood Marrow Transplant
|
|
2018
|
Autologous transplantation in follicular lymphoma with early therapy failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research analysis.
|
Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen AI, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M
|
Biol Blood Marrow Transplant 24(6):1163-1171
|
|
2018
|
Engaging patients in setting a patient-centered outcomes research agenda in hematopoietic cell transplantation.
|
Burns LJ, Abetti B, Arnold SD, Bender J, Doughtie S, El-Jawahiri A, Gee G, Hahn T, Horowitz MM, Johnson S, Juckett M, Krishnamurit L, Kullberg S, LeMaistre CF, Loren A, Majhail NS, Murphy EA, Rizzo D, Roche-Green A, Saber W, Schatz BA, Schmit-Pokorny K, Shaw BE, Syrjala KL, Tierney DK, Ulrich C, Vanness DJ, Wood WA, Denzen EM
|
Biol Blood Marrow Transplant 24(6):1111-1118
|
|
2018
|
Blood and Marrow Transplant Clinical Trials Network report on the development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials.
|
Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH
|
Biol Blood Marrow Transplant 24(6):1274-1280
|
|
2018
|
Evaluation of a machine learning-based prognostic model for unrelated hematopoietic cell transplantation donor selection.
|
Buturovic L, Shelton J, Spellman SR, Wang T, Friedman L, Loftus D, Hesterberg L, Woodring T, Fleischhauer K, Hsu KC, Verneris MR, Haagenson M, Lee SJ
|
Biol Blood Marrow Transplant 24(6):1299-1306
|
|
2018
|
Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation.
|
Zhu Q, Yan L, Liu Q, Zhang C, Wei L, Hu Q, Preus L, Clay-Gilmour AI, Onel K, Stram DO, Pooler L, Sheng X, Haiman CA, Zhu X, Spellman SR, Pasquini M, McCarthy PL, Liu S, Hahn T, Sucheston-Campbell LE
|
Blood 131(22):2490-2499
|
|
2018
|
Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.
|
Gadalla SM, Aubert G, Wang T, Haagenson M, Spellman SR, Wang L, Katki HA, Savage SA, Lee SJ
|
Blood 131(21):2393-2398
|
|
2018
|
Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection.
|
Fleischhauer K, Hsu KC, Shaw BE
|
Bone Marrow Transplant
|
|
2018
|
A cure‐rate model for Q‐learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients.
|
Moodie EEM, Stephens DA, Alam S, Zhang M-J, Logan B, Arora M, Spellman S, Krakow EF
|
Biom J
|
|
2018
|
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.
|
Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, Couriel DR, Alousi AM, Aljurf MD, Cahn J-Y, Cairo MS, Cutler CS, Farhan S, Gergis U, Hale GA, Hashmi SK, Inamoto Y, Kamble RT, Kharfan-Dabaja MA, MacMillan ML, Marks DI, Nakasone H, Norkin M, Qayed M, Ringden O, Schouten HC, Schultz KR, Solh MM, Teshima T, Urbano-Ispizua A, Verdonck LF, Gale RP, Hamilton BK, Majhail NS, Loren AW
|
Blood Advances 2(9):1022-1031
|
|
2018
|
Development of an unrelated donor selection score predictive of survival after HCT: Donor age matters most.
|
Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ
|
Biol Blood Marrow Transplant 24(5):1049-1056
|
|
2018
|
Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT.
|
Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE
|
Bone Marrow Transplant 53(5):535-555
|
|
2018
|
Pretransplant consolidation is not beneficial for adults with ALL undergoing myeloablative allogeneic transplantation.
|
Bejanyan N, Zhang M-J, Wang H-L, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Gale RP, Lazarus HM, Ustun C, Copelan E, Hamilton BK, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, Khoury HJ, Weisdorf DJ
|
Biol Blood Marrow Transplant 24(5):945-955
|
|
2018
|
Variable selection with group structure in competing risks quantile regression.
|
Ahn KW, Kim S
|
Stat Med 37(9):1577-1586
|
|
2018
|
The distribution of HLA haplotypes in the ethnic groups that make up the Brazilian Bone Marrow Volunteer Donor Registry (REDOME).
|
Halagan M, Oliveira D, Maiers M, Fabreti-Oliveira RA, Moraes MEH, Visentainer JEL, Pereira NF, Romero M, Cardoso JF
|
Immunogenetics
|
|
2018
|
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: A CIBMTR analysis.
|
Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen AI, Ciurea SO, Bachanova V, DeFilipp Z, Epperla N, Farhadfar N, Herrera AF, Haverkos BM, Holmberg L, Hossain NM, Kharfan-Dabaja MA, Kenkre VP, Lazarus HM, Murthy HS, Nishihori T, Rezvani AR, D'Souza A, Savani BN, Ulrickson ML, Waller EK, Sureda A, Smith SM, Hamadani M
|
Blood Advances 2(8):933-940
|
|
2018
|
Easy-to-read informed consent form for hematopoietic cell transplantation clinical trials: results from Blood and Marrow Transplant Clinical Trials Network 1205 Trial
|
Spellecy R, Tarima S, Denzen E, Moore H, Abhyankar S, Dawson P, Foley A, Gersten I, Horwitz M, Idossa L, Joffe S, Kamani N, King R, Lazaryan A, Morris L, Horowitz M, Majhail NS
|
Biol Blood Marrow Transplant
|
|
2018
|
Epidemiology and biology of relapse after stem cell transplantation.
|
Horowitz M, Schreiber H, Elder A, Heidenreich O, Vormoor J, Toffalori C, Vago L, Kröger N
|
Bone Marrow Transplant
|
|
2018
|
Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
|
Sureda A, Zhang M-J, Dreger P, Carreras J, Fenske T, Finel H, Schouten H, Montoto S, Robinson S, Smith SM, Boumedil A, Hamadani M, Pasquini MC
|
Cancer 124(8):1733-1742
|
|
2018
|
Impact of HLA alleles on outcomes of allogeneic transplantation for B cell non-Hodgkin lymphomas: A Center for International Blood And Marrow Transplant Research analysis.
|
William BM, Wang T, Haagenson MD, Fleischhauer K, Verneris M, Hsu KC, de Lima MJ, Fernandez-Viña M, Spellman SR, Lee SJ, Hill BT
|
Biol Blood Marrow Transplant 24(4):827-831
|
|
2018
|
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: Low incidence of lower gastrointestinal tract disease.
|
Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M
|
Haematologica 103(4):717-727
|
|
2018
|
No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia.
|
Gadalla SM, Wang T, Loftus D, Friedman L, Dagnall C, Haagenson M, Spellman SR, Buturovic L, Blauwkamp M, Shelton J, Fleischhauer K, Hsu KC, Verneris MR, Krstajic D, Hicks B, Jones K, Lee SJ, Savage SA
|
Bone Marrow Transplant 53(4):383-391
|
|
2018
|
Tandem autologous hematopoietic cell transplantation for patients with primary progressive or recurrent Hodgkin lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network phase II trial (SWOG S0410/BMT CTN 0703).
|
Smith EP, Li H, Friedberg JW, Constine LS, Rimsza LM, Cook JR, Laport GG, Popplewell LL, Holmberg LA, Smith SM, LeBlanc M, Forman SJ, Fisher RI, Stiff P
|
Biol Blood Marrow Transplant 24(4):700-707
|
|
2018
|
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
|
Kumar SK, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, Kharfan-Dabaja M, Freytes C, Hashmi S, Hildebrandt G, Holmberg L, Kyle R, Lazarus H, Lee C, Mikhael J, Nishihori T, Tay J, Usmani S, Vesole D, Vij R, Wirk B, Krishnan A, Gasparetto C, Mark T, Nieto Y, Hari P, D'Souza A
|
Leukemia 32(4):986-995
|
|
2018
|
Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia.
|
Kebriaei P, Anasetti C, Zhang M-J, Wang H-L, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens J-J, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI
|
Biol Blood Marrow Transplant 24(4):726-733
|
|
2018
|
Screening group variables in the proportional hazards model.
|
Ahn KW, Sahr N, Kim S
|
Stat Probab Lett 135:20-25
|
|
2018
|
Burnout, moral distress, work-life balance, and career satisfaction among hematopoietic cell transplantation professionals.
|
Neumann JL, Mau L-W, Virani S, Denzen EM, Boyle DA, Boyle NJ, Dabney J, De KeselLofthus A, Kalbacker M, Khan T, Majhail NS, Murphy EA, Paplham P, Parran L, Perales M-A, Rockwood TH, Schmit-Pokorny K, Shanafelt TD, Stenstrup E, Wood WA, Burns LJ
|
Biol Blood Marrow Transplant 24(4):849-860
|
|
2018
|
BMT CTN Myeloma Intergroup Workshop on minimal residual disease and immune profiling: Summary and recommendations from the organizing committee.
|
Holstein SA, Avet-Loiseau H, Hahn T, Ho CM, Lohr JG, Munshi NC, Paiva B, Pasquini MC, Tario JD Jr, Usmani SZ, Wallace P, Weisel K, McCarthy PL
|
Biol Blood Marrow Transplant 24(4):641-648
|
|
2018
|
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
|
Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano J-A, Pulsipher MA, Baker KS
|
Bone Marrow Transplant
|
|
2018
|
Providing level-of-match information to perfectly matched unrelated donors: Evaluating acceptability and potential changes in donor availability.
|
Switzer GE, Macis M, Fabi R, Abress L, Confer D, Bruce J, Howe K, Fowler S, McNulty M, Pastorek G, Dew MA
|
Biol Blood Marrow Transplant
|
|
2018
|
Country-level macroeconomic indicators predict early post-allogeneic hematopoietic cell transplantation survival in acute lymphoblastic leukemia: A CIBMTR analysis.
|
Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi S, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad A, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W
|
Biol Blood Marrow Transplant
|
|
2018
|
A Group Sequential Test for Treatment Effect based on the Fine-Gray Model.
|
Martens M, Logan BR
|
Biometrics
|
|
2018
|
Influence of age on acute and chronic GVHD in children undergoing HLA-identical sibling bone marrow transplantation for acute leukemia: Implications for prophylaxis.
|
Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J
|
Biol Blood Marrow Transplant 24(3):521-528
|
|
2018
|
Autologous/allogeneic Hematopoietic cell transplantation versus tandem autologous transplantation for multiple myeloma: Comparison of long-term postrelapse survival.
|
Htut M, D'Souza A, Krishnan A, Bruno B, Zhang M-J, Fei M, Diaz MA, Copelan E, Ganguly S, Hamadani M, Kharfan-Dabaja M, Lazarus H, Lee C, Meehan K, Nishihori T, Saad A, Seo S, Ramanathan M, Usmani SZ, Gasparetto C, Mark TM, Nieto Y, Hari P
|
Biol Blood Marrow Transplant 24(3):478-485
|
|
2018
|
Assessment of impact of HLA type on outcomes of allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
|
Hill BT, Ahn KW, Hu Z-H, Aljurf M, Beitinjaneh A, Cahn J-Y, Cerny J, Kharfan-Dabaja MA, Ganguly S, Ghosh N, Grunwald MR, Inamoto Y, Kindwall-Keller T, Nishihori T, Olsson RF, Saad A, Seftel M, Seo S, Szer J, Tallman M, Ustun C, Wiernik PH, Maziarz RT, Kalaycio M, Alyea E, Popat U, Sobecks R, Saber W
|
Biol Blood Marrow Transplant 24(3):581-586
|
|
2018
|
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
|
Myers RM, Hill BT, Shaw BE, Kim S, Millard HR, Battiwalla M, Majhail NS, Buchbinder D, Lazarus HM, Savani BN, Flowers MED, D'Souza A, Ehrhardt MJ, Langston A, Yared JA, Hayashi RJ, Daly A, Olsson RF, Inamoto Y, Malone AK, DeFilipp Z, Margossian SP, Warwick AB, Jaglowski S, Beitinjaneh A, Fung H, Kasow KA, Marks DI, Reynolds J, Stockerl-Goldstein K, Wirk B, Wood WA, Hamadani M, Satwani P
|
Cancer 124(4):816-825
|
|
2018
|
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
|
Shaw BE, Syrjala KL, Onstad LE, Chow EJ, Flowers ME, Jim H, Baker KS, Buckley S, Fairclough DL, Horowitz MM, Lee SJ
|
Cancer 124(4):841-849
|
|
2018
|
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
|
McCurdy SR, Zhang M-J, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales M-A, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M
|
Blood Advances 2(3):299-307
|
|
2018
|
HLA mismatches that are identical for the antigen recognition domain are less immunogenic.
|
Roelen D, de Vaal Y, Vierra-Green C, Waldvogel S, Spellman S, Claas F, Oudshoorn M
|
Bone Marrow Transplant
|
|
2018
|
Current knowledge and practice of pediatric providers in umbilical cord blood banking.
|
Armstrong AE, Fonstad R, Spellman S, Tullius Z, Chaudhury S
|
Clin Pediatr (Phila) 57(2):161-167
|
|
2018
|
Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
|
Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield H-L, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE
|
Biol Blood Marrow Transplant 24(2):228-241
|
|
2018
|
Prediction of acute graft-versus-host disease following hematopoietic cell transplantation.
|
Lee C, Haneuse S, Wang H-L, Rose S, Spellman SR, Verneris MR, Hsu KC, Fleischhauer K, Lee SJ, Abdi R
|
PLoS One 13(1):e0190610
|
|
2018
|
Next generation sequencing characterizes the extent of HLA diversity in an Argentinian registry population.
|
Hurley CK, Hou L, Lazaro A, Gerfen J, Enriquez E, Galarza P, Cardozo MBR, Halagan M, Maiers M, Behm D, Ng J
|
HLA
|
|
2018
|
Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.
|
Turcotte LM, DeFor TE, Newell LF, Cutler CS, Verneris MR, Wu J, Howard A, MacMillan ML, Antin JH, Vercellotti GM, Slungaard A, Blazar BR, Weisdorf DJ, Panoskaltsis-Mortari A, Holtan SG
|
Bone Marrow Transplant 53(1):64-68
|
|
2018
|
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
|
Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora K-W, Tamura S, Taskinen M, Wawer A, Wolska-Kuśnierz B, Cowan MJ, Fischer A, Gennery AR
|
J Allergy Clin Immunol 141(1):322-328.e10
|
|
2018
|
Fludarabine and busulfan versus fludarabine, cyclophosphamide, and rituximab as reduced-intensity conditioning for allogeneic transplantation in follicular lymphoma.
|
Epperla N, Ahn KW, Armand P, Jaglowski S, Ahmed S, Kenkre VP, Savani B, Jagasia M, Shah NN, Fenske TS, Sureda A, Smith SM, Hamadani M
|
Biol Blood Marrow Transplant 24(1):78-85
|
|
2018
|
Donor experiences of second marrow or peripheral blood stem cell collection mirror the first, but CD34+ yields are less.
|
Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA
|
Biol Blood Marrow Transplant 24(1):175-184
|
